Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis

NCT03178487 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03178487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03178487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis
Lead sponsor
AbbVie
Phase
Phase 2
Overall status
Completed
Start date
October 24, 2017
Completion date
February 17, 2022
Enrollment
187 (actual)
Sites
101

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis (as)